Skip to Content

Cibus, Inc.

Company NameCibus, Inc.
Stock SymbolCBUS

On June 4, 2024, Bonitas Research published a report alleging, among other things, that there is “no evidence that Cibus’ gene-editing technology brings desirable new crops to market,” and, instead, there are “farmer complaints of lower crop yields and lost revenues, along with multiple examples of large seed manufacturers and distributors walking away from joint ventures and partnerships with Cibus for a variety of seed types and seed traits.”

On this news, Cibus’ stock price fell as much as 13% during intraday trading on June 4, 2024, thereby injuring investors.

Submit Your Information

If you suffered a loss on your Cibus, Inc. investments or would like to inquire about joining an action to recover your loss under the federal securities laws, please complete the form below. Please note that submission of this form does not by itself form an attorney-client relationship nor does filing out this form mean you have joined any lawsuit.

Shares Purchased

Number of SharesBuy DatePrice Per ShareAdd

Shares Sold

Number of SharesSell DatePrice Per ShareAdd